ArticleCell death discovery2026

Targeting NXPH4/ALDH1L2 signaling suppresses enzalutamide resistance in prostate cancer.

Xianchao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.